Medical News

RSS

Heavy snorers at increased risk of stroke

University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.

4 Sep 2008

Low-birth-weight children should have their blood pressure checked

Blood pressure in low-birth-weight children younger than 3 years of age not only can be measured but should be, researchers at UT Southwestern Medical Center have found.

4 Sep 2008

African countries commit to new meningitis vaccine

Health ministers from countries of the African meningitis belt today committed themselves to introduce a highly promising candidate meningitis vaccine. The vaccine is designed to prevent periodic epidemics of the deadly disease in these countries.

4 Sep 2008

$FDA approves Medtronic software update that will help detect fractures in cardiac defibrillator leads$

FDA approves Medtronic software update that will help detect fractures in cardiac defibrillator leads

The U.S. Food and Drug Administration today announced approval of a software update from Medtronic that will help detect fractures of the company's Sprint Fidelis cardiac defibrillator lead.

4 Sep 2008

St. Lucia developing HIV/AIDS policy for education system

Stakeholders involved in St. Lucia's education system met last week to commence work on an HIV/AIDS policy for the sector, the Caribbean Media Corporation/Antigua Sun reports.

4 Sep 2008

HIV/AIDS, human rights charter proposed in Zimbabwe

An HIV/AIDS and human rights charter that aims to protect and promote the rights of people living with the disease was proposed recently by the Zimbabwe Lawyers for Human Rights, the Zimbabwe Standard reports.

4 Sep 2008

Sexual activities other than intercourse carry risk of HIV, other STIs, study finds

Sexual activities other than intercourse carry some risk of HIV and other sexually transmitted infections, according to a report from the American College of Obstetricians and Gynecologists published recently in the journal Obstetrics and Gynecology, Reuters reports.

4 Sep 2008

Gilead's antiretroviral patent request rejected by Brazil

A patent request from the pharmaceutical company Gilead for its antiretroviral drug tenofovir was rejected by Brazil Wednesday, Reuters reports.

4 Sep 2008

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.

4 Sep 2008

Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer

According a new study, unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target.

4 Sep 2008

FDA 'fast track' granted to BioMS Medical for lead drug, dirucotide for the treatment of multiple sclerosis

BioMS Medical Corp has announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients.

4 Sep 2008

FDA assigns priority review to ATryn from GTC Biotherapeutics

The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s Biologic License Application, or BLA, for ATryn.

4 Sep 2008

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

Celgene Corporation today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.

4 Sep 2008

New research settles measles vaccine/autism controversy

New research from the United States will hopefully settle once and for all the controversial debate about a link between the measles vaccine and autism.

4 Sep 2008

Invitrogen launches patent licensing program for random prime amplification of nucleic acids

Invitrogen Corporation today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard & Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen's patented technology covering the random prime amplification of nucleic acids. Financial terms of the agreements were not disclosed.

4 Sep 2008

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Cancer drug developer Antisoma plc today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma (kidney cancer).

4 Sep 2008

Domestic HIV/AIDS spending 'essentially flat,' increased 'efforts to control' HIV from 'all levels of Government' needed, editorial says

It has been "difficult over the years to get a good statistical handle on the size of the AIDS problem in this country," a New York Times editorial says, adding, "But by the latest and most sophisticated measurements, the disease continues to frustrate federal and local efforts to rein it in."

4 Sep 2008

Georgia approves HMO fee to help fund state Medicaid program

The Georgia Department of Community Health board on Thursday approved a plan to charge commercial HMOs the same fee as managed care companies that operate the state's Medicaid program in an effort to make up for a 5% reduction in program funding, the Savannah Morning News reports.

4 Sep 2008

HMOs to stay in Florida Medicaid reform program after agency for health care administration agrees to lower payment cuts

Three Florida HMOs have said they will continue participating in a "Medicaid Reform" plan after the Agency for Health Care Administration agreed to reduce payments by an average of 3% on Sept. 1, instead of 5% as previously announced, Florida Health News reports (Florida Health News, 9/2).

4 Sep 2008

Proposed medical loss ratio requirement in California would not address rising health care costs, insurers say

California health insurers say legislation that would require them to spend at least 85% of premium revenue on health benefit expenses would not address the underlying causes of rising health care costs or improve the quality of care, the Wall Street Journal reports.

4 Sep 2008

Medical News

Heavy snorers at increased risk of stroke

Low-birth-weight children should have their blood pressure checked

African countries commit to new meningitis vaccine

FDA approves Medtronic software update that will help detect fractures in cardiac defibrillator leads

St. Lucia developing HIV/AIDS policy for education system

HIV/AIDS, human rights charter proposed in Zimbabwe

Sexual activities other than intercourse carry risk of HIV, other STIs, study finds

Gilead's antiretroviral patent request rejected by Brazil

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer

FDA 'fast track' granted to BioMS Medical for lead drug, dirucotide for the treatment of multiple sclerosis

FDA assigns priority review to ATryn from GTC Biotherapeutics

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

New research settles measles vaccine/autism controversy

Invitrogen launches patent licensing program for random prime amplification of nucleic acids

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Domestic HIV/AIDS spending 'essentially flat,' increased 'efforts to control' HIV from 'all levels of Government' needed, editorial says

Georgia approves HMO fee to help fund state Medicaid program

HMOs to stay in Florida Medicaid reform program after agency for health care administration agrees to lower payment cuts

Proposed medical loss ratio requirement in California would not address rising health care costs, insurers say

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News